Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Blind Procedures02:07

Blind Procedures

13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
Understanding Deception01:14

Understanding Deception

233
Deception is a pervasive aspect of human communication. Empirical studies have shown that most individuals engage in some form of deceit on a daily basis, with approximately 20% of social exchanges involving deceptive elements. Lying follows a developmental trajectory, peaking during adolescence and declining with age, possibly due to the maturation of cognitive control and social accountability.Cognitive and Social Factors in Deception DetectionDespite its prevalence, accurately detecting...
233
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
Ethics in Research01:56

Ethics in Research

26.2K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
26.2K
Blinding01:11

Blinding

4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Amyloid A-Dependent Inflammasome Activation and Acute Injury in a Mouse Model of Experimental Stroke.

International journal of molecular sciences·2026
Same author

Risk of new-onset diabetes with high-intensity statin use.

The lancet. Diabetes & endocrinology·2024
Same author

The Metabolic and Endocrine Effects of a 12-Week Allulose-Rich Diet.

Nutrients·2024
Same author

Opinion: Are mental health benefits of the ketogenic diet accompanied by an increased risk of cardiovascular disease?

Frontiers in nutrition·2024
Same author

Serum amyloid A-dependent inflammasome activation and acute injury in a mouse model of experimental stroke.

Research square·2023
Same author

Correction: Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy.

Cureus·2023

Related Experiment Video

Updated: Mar 31, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Additional commentary on deception in statin research.

David M Diamond1,2,3, Uffe Ravnskov4

  • 1a Medical Research Service , Veterans Hospital , Tampa , 33612 FL , USA.

Expert Review of Clinical Pharmacology
|October 27, 2015
PubMed
Summary
This summary is machine-generated.

Absolute risk reduction is influenced by the length of patient follow-up. This analysis highlights the critical role of follow-up duration in interpreting clinical trial results for risk reduction therapies.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K

Related Experiment Videos

Last Updated: Mar 31, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K

Area of Science:

  • Clinical pharmacology
  • Evidence-based medicine
  • Biostatistics

Background:

  • Interpreting the clinical significance of therapeutic interventions requires careful consideration of various factors.
  • Absolute risk reduction (ARR) is a key metric for evaluating treatment efficacy.
  • The duration of patient follow-up in clinical trials can impact the observed ARR.

Purpose of the Study:

  • To discuss how the duration of follow-up influences the calculation and interpretation of absolute risk reduction.
  • To emphasize the importance of considering follow-up length when assessing treatment benefits.

Main Methods:

  • This is a response to a published article, involving critical analysis of existing data and concepts.
  • Review of statistical principles related to risk assessment in clinical studies.

Main Results:

  • Absolute risk reduction estimates are not static and can change significantly with extended follow-up periods.
  • The observed benefit of an intervention may appear different depending on the time frame analyzed.

Conclusions:

  • Clinicians and researchers must account for follow-up duration when evaluating absolute risk reduction to accurately gauge treatment effectiveness.
  • Standardizing follow-up periods or clearly reporting results stratified by duration is crucial for reliable interpretation of therapeutic benefits.